Products
Technology
Find out more about our extensive library of patented cytochrome P450 enzymes.
Latest news
Oxford Biotrans raises £2.1 million
10th October 2017 Oxford Biotrans has announced that it has closed £2.1m in new funding. The investment was led by Touchstone Innovations (formerly Imperial Innovations)
Where we are based